KERYX BIOPHARMACEUTICALS INC

CUSIP: 492515101 Class: COMMON STOCK

Prospect Capital Advisors, LLC's Holding History (CIK: 0001632368)

Note: Option positions (PUT/CALL) are excluded.

Q4 2017
Shares 149,745 Value ($000) $696 Avg Close — Range —
Q3 2017
Shares 149,745 Value ($000) $1,063 Avg Close — Range —
Q2 2017
Shares 149,745 Value ($000) $1,083 Avg Close — Range —
Q1 2017
Shares 100,000 Value ($000) $616 Avg Close — Range —